Furthermore, we will elucidate the therapeutic potential of cynaroside in ameliorating NASH with T2DM through the regulation of HMGCS2-dependent ketogenesis and explore its underlying molecular mechanisms. This evidence concerns the gene HMGCS2 and type 2 diabetes mellitus.